Published in Mol Immunol on November 01, 1984
Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides. Clin Diagn Lab Immunol (2003) 3.27
Seroprevalence of immunoglobulin M (IgM) and IgG antibodies to polysaccharides of Streptococcus pneumoniae in different age groups of Ecuadorian and German children. J Clin Microbiol (1992) 1.00
Effect of malnutrition in Ecuadorian children on titers of serum antibodies to various microbial antigens. Clin Diagn Lab Immunol (1995) 0.88
Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis (1983) 6.15
Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens. N Engl J Med (1980) 3.95
Prevention of pneumococcal pneumonia by vaccination. Trans Assoc Am Physicians (1976) 3.49
Hyperglycemia-induced hyponatremia--calculation of expected serum sodium depression. N Engl J Med (1973) 3.21
Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med (1984) 2.97
Past and current roles for cephalosporin antibiotics in treatment of meningitis. Emphasis on use in gram-negative bacillary meningitis. Am J Med (1981) 2.68
A radioimmunoassay for immunologic phenomena in pneumococcal disease and for the antibody response to pneumococcal vaccines. I. Method for the radioimmunoassay of anticapsular antibodies and comparison with other techniques. J Immunol Methods (1980) 2.65
B-cell immunodeficiency in acquired immune deficiency syndrome. JAMA (1984) 2.63
Acquired immune deficiency in Haitians: opportunistic infections in previously healthy Haitian immigrants. N Engl J Med (1983) 2.36
Immune response after splenectomy. Lancet (1978) 2.31
Diffusion of a new beta-lactam (LY 127935) into cerebrospinal fluid. Implications for therapy of gram-negative bacillary meningitis. Am J Med (1980) 2.14
Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa. Antimicrob Agents Chemother (1980) 2.12
Immunodeterminant specificity of human immunity to type III group B streptococcus. J Exp Med (1979) 2.06
Bacterial pneumonia in patients with the acquired immunodeficiency syndrome. Ann Intern Med (1986) 1.99
Refinements in stress echocardiographic techniques improve inter-institutional agreement in interpretation of dobutamine stress echocardiograms. Eur Heart J (2002) 1.87
Impaired antibody response to pneumococcal vaccine after treatment for Hodgkin's disease. N Engl J Med (1978) 1.86
Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors. Sex Transm Dis (1996) 1.84
The AIDS epidemic. N Engl J Med (1985) 1.82
The role of the capsular polysaccharide in the activation of the alternative pathway by the pneumococcus. J Immunol (1976) 1.80
Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates. Infect Immun (1986) 1.79
Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study. N Engl J Med (1986) 1.76
Assessment of the antibody response to pneumococcal vaccine in high-risk populations. Rev Infect Dis (1981) 1.71
Capsulation of pneumococcus with soluble C-like (Cs) polysaccharide. I. Biological and genetic properties of Cs pneumococcal strains. J Exp Med (1968) 1.65
Recovery of norfloxacin in feces after administration of a single oral dose to human volunteers. Antimicrob Agents Chemother (1984) 1.63
Streptococcus pneumoniae infections and bacteremia in patients with acquired immune deficiency syndrome, with report of a pneumococcal vaccine failure. Am Rev Respir Dis (1984) 1.62
Comparative immunogenicity of group 6 pneumococcal type 6A(6) and type 6B(26) capsular polysaccharides. Infect Immun (1979) 1.61
A probability graph describing the predictive value of a highly sensitive diagnostic test. N Engl J Med (1974) 1.58
Impaired antibody responses to pneumococcal polysaccharide in elderly patients with low serum vitamin B12 levels. Ann Intern Med (1996) 1.52
Failure of pneumococcal vaccine in children with sickle-cell disease. N Engl J Med (1979) 1.43
Experimental otitis media after nasal inoculation of Streptococcus pneumoniae and influenza A virus in chinchillas. Infect Immun (1980) 1.43
Early diagnosis of HIV infection in infants by detection of IgA HIV antibodies. Lancet (1990) 1.41
Iron status in patients receiving erythropoietin for dialysis-associated anemia. Kidney Int (1989) 1.39
Response to pneumococcal polysaccharide vaccine in patients with untreated Hodgkin's disease. Children's Cancer Study Group Report. Lancet (1980) 1.35
Some biological properties of Pneumococcus type 37 and the chemistry of its capsular polysaccharide. J Exp Med (1970) 1.34
Serum antibody and opsonic responses to vaccination with pneumococcal capsular polysaccharide in normal and splenectomized children. J Infect Dis (1980) 1.32
Correlation between G2m(n) immunoglobulin allotype and human antibody response and susceptibility to polysaccharide encapsulated bacteria. J Clin Invest (1985) 1.32
Passive immunization against disease due to Haemophilus influenzae type b: concentrations of antibody to capsular polysaccharide in high-risk children. J Infect Dis (1986) 1.30
Afriflu--international conference on influenza disease burden in Africa, 1-2 June 2010, Marrakech, Morocco. Vaccine (2010) 1.28
Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers. Women and Infants Transmission Study. J Infect Dis (1998) 1.26
Current concepts. Treatment of infections associated with human immunodeficiency virus. N Engl J Med (1988) 1.26
Isotypes and opsonophagocytosis of pneumococcus type 6B antibodies elicited in infants and adults by an experimental pneumococcus type 6B-tetanus toxoid vaccine. Infect Immun (1998) 1.24
Pneumococcal infections after human bone-marrow transplantation. Ann Intern Med (1979) 1.23
Modification of otitis media following vaccination with the capsular polysaccharide of Streptococcus pneumoniae in chinchillas. J Infect Dis (1978) 1.21
Need for agreement on a single pneumococcal vaccine formulation. Lancet (1980) 1.21
Epidemiologic studies of Streptococcus pneumoniae in infants: antibody response to nasopharyngeal carriage of types 3, 19, and 23. J Infect Dis (1981) 1.21
Serum antibody response in adult volunteers elicited by injection of Streptococcus pneumoniae type 12F polysaccharide alone or conjugated to diphtheria toxoid. Infect Immun (1990) 1.20
Recurrent Salmonella typhimurium bacteremia associated with the acquired immunodeficiency syndrome. Ann Intern Med (1985) 1.17
Evaluation of the sigmoid notch with computed tomography following intra-articular distal radius fracture. J Hand Surg Am (2001) 1.17
Clinical studies of pneumococcal vaccines in infants. I. Reactogenicity and immunogenicity of two polyvalent polysaccharide vaccines. Rev Infect Dis (1981) 1.15
Acetazolamide in studying sodium reabsorption in diluting segment. Am J Physiol (1970) 1.14
Measurement of intrarenal blood flow. I. Analysis of microsphere method. Am J Physiol (1971) 1.14
Serum antibody response to pneumococcal vaccine in children with nephrotic syndrome. Pediatrics (1982) 1.13
Pneumococcal infection and immunologic response to pneumococcal vaccine in chronic obstructive pulmonary disease. A pilot study. Chest (1987) 1.13
The presence of sialic acid on two related bacterial polysaccharides determines the site of the primary immune response and the effect of complement depletion on the response in mice. J Immunol (1982) 1.12
Synthesis and physicochemical and immunological characterization of pneumococcus type 12F polysaccharide-diphtheria toxoid conjugates. Infect Immun (1988) 1.12
Immunologic studies in pneumococcal disease. J Lab Clin Med (1977) 1.12
Preparation of human hyperimmune globulin to Haemophilus influenzae b, Streptococcus pneumoniae, and Neisseria meningitidis. Infect Immun (1984) 1.12
Infections in children with sickle cell anemia. Special reference to pneumococcal and salmonella infections. Am J Pediatr Hematol Oncol (1982) 1.11
Incidence and risk factors for heterosexually acquired HIV in an inner-city cohort of women: temporal association with pregnancy. J Acquir Immune Defic Syndr Hum Retrovirol (1999) 1.10
HIV prevalence, immunosuppression, and drug resistance in patients with tuberculosis in an area endemic for AIDS. AIDS (1991) 1.09
Measurement of intrarenal blood flow. II. Effect of saline diuresis in the dog. Am J Physiol (1971) 1.08
Effect of chronic exposure of PCB (Aroclor 1254) on specific and nonspecific immune parameters in the rhesus (Macaca mulatta) monkey. Fundam Appl Toxicol (1991) 1.08
Maternal-fetal transfer of pneumococcal capsular polysaccharide antibodies. Am J Dis Child (1985) 1.08
Antibody response to vaccination with pneumococcal capsular polysaccharides in splenectomized children. Acta Paediatr Scand (1982) 1.08
Correlation of serum opsonins with in vitro phagocytosis of Streptococcus pneumoniae. Infect Immun (1985) 1.08
Influence of preimmunization antibody levels on the specificity of the immune response to related polysaccharide antigens. N Engl J Med (1980) 1.07
Immunization of immunosuppressed patients with pneumococcal polysaccharide vaccine. Rev Infect Dis (1981) 1.06
Factors associated with cytomegalovirus infection among human immunodeficiency virus type 1-seronegative and -seropositive women from an urban minority community. J Infect Dis (1996) 1.06
The case for routinely offering prenatal testing for human immunodeficiency virus. Am J Obstet Gynecol (1988) 1.05
Revaccination of renal transplant and hemodialysis recipients with pneumococcal vaccine. Arch Intern Med (1986) 1.04
Response to pneumococcal vaccine among asymptomatic heterosexual partners of persons with AIDS and intravenous drug users infected with human immunodeficiency virus. J Infect Dis (1989) 1.04
Hepatitis C virus infection in the mothers and infants cohort study. Pediatrics (1998) 1.04
Netilmicin in gram-negative bacterial infections. Antimicrob Agents Chemother (1979) 1.04
Subpopulations of antibodies to phosphocholine in human serum. J Immunol (1984) 1.04
Immune response to acute otitis media: association between middle ear fluid antibody and the clearing of clinical infection. J Clin Microbiol (1976) 1.04
Studies on Pneumococcus vaccine alone or mixed with DTP and on Pneumococcus type 6B and Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugates in two- to five-year-old children with sickle cell anemia. Pediatr Infect Dis J (1990) 1.03
The antibody responses to pneumococcal capsular polysaccharides in aged individuals. Proc Soc Exp Biol Med (1980) 1.02
Pharmacokinetics of an immediate-release oral formulation of Fampridine (4-aminopyridine) in normal subjects and patients with spinal cord injury. J Clin Pharmacol (2003) 1.02
What are the most sensitive and specific sign and symptom combinations for influenza in patients hospitalized with acute respiratory illness? Results from western Kenya, January 2007-July 2010. Epidemiol Infect (2012) 1.01
Clinical studies of pneumococcal vaccines in infants. II. Efficacy and effect on nasopharyngeal carriage. Rev Infect Dis (1981) 1.00
Probable Mycobacterium fortuitum septicemia: complication of home dialysis. Lancet (1971) 0.99
Experimental otitis media in chinchillas following nasal colonization with type 7F Streptococcus pneumoniae: prevention after vaccination with pneumococcal capsular polysaccharide. J Infect Dis (1979) 0.99
Immunoregulatory role of the spleen in antibody responses to pneumococcal polysaccharide antigens. Infect Immun (1987) 0.99
Selective defect in the antibody response to Haemophilus influenzae type b in children with recurrent infections and normal serum IgG subclass levels. J Allergy Clin Immunol (1988) 0.98
Effect of saline diuresis on intrarenal blood flow in the rat. Am J Physiol (1971) 0.97
Immune responses of infants vaccinated with serotype 6B pneumococcal polysaccharide conjugated with tetanus toxoid. Pediatr Infect Dis J (1997) 0.97
Long-term persistence of antibody following immunization with pneumococcal polysaccharide vaccine. Proc Soc Exp Biol Med (1983) 0.97
Contribution of acetabular labrum to articulating surface area and femoral head coverage in adult hip joints: an anatomic study in cadavera. Am J Orthop (Belle Mead NJ) (2001) 0.97
Pneumococcal vaccine: a tool for the evaluation of the B-cell function of the immune system. Proc Soc Exp Biol Med (1983) 0.97
Immunological function in post-traumatic splenosis. Clin Immunol Immunopathol (1995) 0.96
Pneumococcal vaccine in normal children. Primary and secondary vaccination. Am J Dis Child (1983) 0.95
Antibody response to pretreatment immunization and post-treatment boosting with bacterial polysaccharide vaccines in patients with Hodgkin's disease. Ann Intern Med (1986) 0.95
Decline of serum antibody in splenectomized children after vaccination with pneumococcal capsular polysaccharides. J Pediatr (1984) 0.95
Response of patients with Hodgkin's disease to pneumococcal vaccine. Ann Intern Med (1979) 0.95
Synthesis of a conjugate vaccine composed of pneumococcus type 14 capsular polysaccharide bound to pertussis toxin. Infect Immun (1992) 0.95
Vaccine-type pneumococcal pneumonia. Occurrence after vaccination in an asplenic patient. JAMA (1979) 0.95
Revaccination with pneumococcal vaccine of elderly persons 6 years after primary vaccination. Vaccine (1991) 0.95